Details for New Drug Application (NDA): 064065
✉ Email this page to a colleague
The generic ingredient in OTICAIR is hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are sixty-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 064065
Tradename: | OTICAIR |
Applicant: | Bausch And Lomb |
Ingredient: | hydrocortisone; neomycin sulfate; polymyxin b sulfate |
Patents: | 0 |
Pharmacology for NDA: 064065
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 064065
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OTICAIR | hydrocortisone; neomycin sulfate; polymyxin b sulfate | SUSPENSION/DROPS;OTIC | 064065 | ANDA | Bausch & Lomb Incorporated | 24208-635 | 24208-635-62 | 1 BOTTLE, DROPPER in 1 CARTON (24208-635-62) / 10 mL in 1 BOTTLE, DROPPER |
OTICAIR | hydrocortisone; neomycin sulfate; polymyxin b sulfate | SUSPENSION/DROPS;OTIC | 064065 | ANDA | RPK Pharmaceuticals, Inc. | 53002-9000 | 53002-9000-1 | 1 BOTTLE, DROPPER in 1 CARTON (53002-9000-1) / 10 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION/DROPS;OTIC | Strength | 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML | ||||
Approval Date: | Aug 28, 1996 | TE: | AT | RLD: | No |
Complete Access Available with Subscription